EMEA-000306-PIP01-08-M04

Key facts

Invented name
Elonva
Active substance
corifollitropin alfa
Therapeutic area
Endocrinology-Gynaecology-Fertility-Metabolism
Decision number
P/0143/2019
PIP number
EMEA-000306-PIP01-08-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of hypogonadotrophic hypogonadism
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Merck, Sharp & Dohme (Europe) Inc.

Tel. +31 412770000
E-mail: regaffairseurope@organon.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000306-PIP01-08-M04
Compliance opinion date
29/01/2021
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating